Skip to main content
. 2021 May 9;11(5):850. doi: 10.3390/diagnostics11050850

Table 4.

Clinical/paraclinical data of the groups with/without in-hospital complications in ACS patients.

Data Clinical/Paraclinical Parameters No Complications
(n = 743)
Complications
(n = 193)
p
Demographics Age (Years) 64.51 ± 11.66 70.03 ± 11.28 <0.001
Male 488/743 (65.68%) 113/193 (58.55%) 0.085
BMI (kg/m²) 31.15 ± 5.38 29.90 ± 4.82 0.002
Previous history Smoking 190/743 (25.57%) 34/193 (17.61%) 0.021
Diabetes Mellitus 225/743 (30.28%) 69/193 (35.75%) 0.148
Hypertension 524/743 (70.52%) 101/193 (52.33%) <0.001
Dyslipidemia 360/743 (48.45%) 64/193 (33.16%) <0.001
Diagnosis UA 39/743 (53.56%) 43/193 (22.28%) <0.001
NSTEMI 83/743 (11.17%) 30/193 (15.54%) 0.109
STEMI 261/743 (35.13%) 120/193 (62.17%) <0.001
Number of Diseased Vessels 1 198/605 (32.73%) 43/115 (37.39%) 0.146
2 154/605 (25.45%) 24/115 (20.87%) 0.06
3 184/605 (30.41%) 44/115 (38.26%) 0.003
CBC HGB (g/dL) 13.84 ± 1.76 12.04 ± 2.09 <0.001
WBC(×10³/μL) 10.18 ± 3.75 13.38 ± 6.38 <0.001
NEU(×10³/μL) 7.16 ± 3.52 10.13 ± 5.98 <0.001
LYM(×10³/μL) 2.15 ± 0.94 2.23 ± 1.49 0.37
PLT (×10³/μL) 225.83 ± 71.45 230.56 ± 79.12 0.42
PDW (%) 20.08 ± 1.21 20.15 ± 1.42 0.53
MPV(fl) 8.37 ± 1.88 8.16 ± 1.88 0.21
NLR 3.41 ± 3.94 5.30 ± 5.90 <0.001
PLR 1267.21 ± 80.39 150.59 ± 107.62 0.013
RDW (%) 12.31 ± 1.41 13.02 ± 1.56 <0.001
Coagulation Tests APTT(s) 31.80 ± 17.49 34.20 ± 15.38 0.18
PT(s) 15.20 ± 6,69 16.86 ± 6.27 0.018
Cholesterol (mg/dL) - 177.34 ± 47.98 173.81 ± 45.72 0.34
Creatinine (mg/dL) - 1.01 ± 0.51 1.45 ± 0.96 <0.001
LVEF% - 47.74 ± 8.16 38.89 ± 10.90 <0.001

Legend: BMI—body mass index; UA—unstable angina; NSTEMI—non ST elevation myocardial infarction; STEMI—ST elevation myocardial infarction; CBC—complete blood count; HGB—hemoglobin; WBC—white blood cells; NEU—neutrophils; LYM—lymphocytes; PLT—platelets; PDW—platelet distribution width; MPV—mean platelet volume; NLR—neutrophils to lymphocyte ratio; PLR—platelet to lymphocyte ratio; RDW—red cell distribution width; APTT—activated partial thromboplastin time; PT—prothrombin time; LVEF—left ventricular ejection fraction.